Castle Biosciences, Inc. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
CSTL Nasdaq 8071 castlebiosciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Castle Biosciences, Inc.

Castle Biosciences (CSTL) Stock Sees Split Analyst Revisions As Price Targets Come Down - Jun 26th, 2026 4:07 am
DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy - Jun 25th, 2026 2:30 pm
Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal - Jun 23rd, 2026 5:00 am
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 19th, 2026 5:00 am
Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus - Jun 16th, 2026 5:00 am
How The Castle Biosciences (CSTL) Investment Story Is Evolving Without Fresh Analyst Commentary - Jun 9th, 2026 5:07 am
How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets - May 24th, 2026 10:13 am
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference - May 13th, 2026 5:00 am
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation - May 12th, 2026 5:00 am
Castle Biosciences, Inc. Q1 2026 Earnings Call Summary - May 6th, 2026 6:22 pm
Castle Biosciences Q1 Earnings Call Highlights - May 6th, 2026 6:07 pm
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates - May 6th, 2026 4:30 pm
Castle Biosciences Reports First Quarter 2026 Results - May 6th, 2026 2:05 pm
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises - May 6th, 2026 10:06 am
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook - May 6th, 2026 10:01 am
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus - May 6th, 2026 9:57 am
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises - May 6th, 2026 9:50 am
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations - May 6th, 2026 8:29 am
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised - May 5th, 2026 11:17 am
Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus - May 5th, 2026 10:59 am